Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MObility ImproVEment with spasticity in multiple sclerosis in Europe: the MOVE 1 EU study.
Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation.
Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis.
Autoantibodies in pre-clinical autoimmune disease.
Autologous bone marrow transplantation for the treatment of multiple sclerosis.
Sound Lateralization Test Distinguishes Unimpaired MS Patients from Healthy Controls.
Neuroinflammatory changes negatively impact on LTP: A focus on IL-1β
MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells.
Increased HLA-E expression in white matter lesions in multiple sclerosis.
Ongoing clinical trials of TYSABRI
Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging.
Magnetic resonance imaging of blood brain/nerve barrier dysfunction and leukocyte infiltration: closely related or discordant?
Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.
DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications.
Demographic and clinical factors associated with changes in employment in multiple sclerosis.
Physical Activity in Multiple Sclerosis: A Comparative Study of Vitamin D, Brain-Derived Neurotrophic Factor and Regulatory T Cell Populations.
Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis.
[Teriflunomide is a new peroral disease-modifying drug for multiple sclerosis (a review)].
Elevated Expression of Fractalkine (CX3CL1) and Fractalkine Receptor (CX3CR1) in the Dorsal Root Ganglia and Spinal Cord in Experimental Autoimmune Encephalomyelitis: Implications in Multiple Sclerosis-Induced Neuropathic Pain.
Pituitary apoplexy presented with optic neuritis.
[Diagnosis and treatment of neuromyelitis optica.]
Multiple sclerosis and susceptibility to cardiovascular diseases: Implications of ethnicity-related interleukin-17A gene polymorphism?
Monoclonal Antibodies for Multiple Sclerosis Treatment.
Erratum.
Pages
« first
‹ previous
…
473
474
475
476
477
478
479
480
481
…
next ›
last »